Published in Minerva Urol Nefrol on October 15, 1987
Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer. J Clin Oncol (2005) 1.85
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. J Clin Oncol (1999) 1.51
3-month formulation of goserelin acetate ('Zoladex' 10.8-mg depot) in advanced prostate cancer: results from an Italian, open, multicenter trial. Urol Int (2003) 0.94
Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients. Eur Urol (1998) 0.81
Immunophenotypic characterization of the bladder mucosa infiltrating lymphocytes after intravesical BCG treatment for superficial bladder carcinoma. Eur Urol (1992) 0.76
Sustained response following sorafenib therapy in an older adult patient with advanced renal cancer on hemodialysis: a case report. Med Oncol (2010) 0.76
Intra-renal reflux. Urol Res (1985) 0.76
Late effects of intravesical bacillus Calmette-Guérin immunotherapy on bladder mucosa infiltrating lymphocytes: an immunohistochemical study. Eur Urol (1995) 0.76
[Radical prostatectomy: role of ultrasonography in the follow-up]. Arch Ital Urol Nefrol Androl (1992) 0.75
[Radiologic and urodynamic aspects of the myelodysplastic urethra]. Minerva Urol Nefrol (1987) 0.75
[Mono-symptomatic hematuria: first symptom of metastatic pulmonary carcinoma]. Arch Ital Urol Nefrol Androl (1991) 0.75
[Extrinsic ureteral endometriosis: description of a case]. Arch Ital Urol Nefrol Androl (1990) 0.75
[Inverted papilloma associated with transitional cell carcinoma in the upper urinary tract: report of one case and review of the literature]. Arch Ital Urol Nefrol Androl (1990) 0.75
[Usefulness of PSA density (PSAD) in the differential diagnosis between prostatic adenocarcinoma and benign ++ prostatic hypertrophy]. Arch Ital Urol Androl (1994) 0.75
[Cellular proliferation, expression of p53, EGFR and apoptosis index of healthy mucosa of the bladder with TCC; pre- and post-intravesical BCG immunohistochemical study]. Arch Ital Urol Androl (1997) 0.75
[Study of the diuretic efficacy and tolerability of therapy with Rocchetta mineral water in patients with recurrent calcium kidney stones]. Arch Ital Urol Androl (1999) 0.75
Aztreonam monotherapy as prophylaxis in transurethral resection of the prostate: a multicenter study. Rev Infect Dis (1991) 0.75
[Iontophoresis in the conservative treatment of Peyronie's disease: preliminary experience]. Arch Ital Urol Androl (1997) 0.75
A model to assess the risk of recurrences of superficial bladder carcinoma. A preliminary report based on 27 patients with a two-year follow-up. Pathologica (1993) 0.75
[Cystic nephroma: report of two cases and review of literature]. Arch Ital Urol Nefrol Androl (1990) 0.75
[The urologist confronted by the myelodysplasic patient]. Minerva Pediatr (1984) 0.75
[Doppler velocimetry]. Arch Ital Urol Androl (1994) 0.75
[Management of sexual disorders in the diabetic patient. Considerations on diagnosis and therapy based on current pathogenetic and physiopathologic knowledge]. Arch Ital Urol Androl (1995) 0.75